Incyte: Ph3 INCB 39110-309 Itacitinib/Placebo + Corticosteroids in cGVHD - Clinical Trial
What is the Purpose of this Study?
Who Can Participate in the Study?
- Have GVHD
- Have underwent allo-HCT from any donor HLA type (related or unrelated donor with any degree of HLA matching) using any graft source (bone marrow, peripheral blood stem cells, or cord blood)
What is Involved?
If you choose to join this study, you will have:
- A screening visit
- To take the study drug, itacitinib, by mouth
- A physical exam and the doctor will go over any side effects that you may have experienced
- A review of your ability to perform daily activities
- Blood tests
- An ECG/EKG done
- An assessment of your cGVHD symptoms
- To complete Quality of Life questionnaires